Animace načítání

Stránka se připravuje...

Přihlásit se Registrovat se
28 181 právních předpisů

Další údaje zde

Technická podpora

Poskytujeme technickou podporu zdarma

Zavolejte nám

+420 777 717 492

Plné znění - 32021R0849

  1. Úvodní strana
  2. Právní předpisy EU
  3. Plné znění - 32021R0849

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

Chci získat výhodný přístup

XXXXXXXX XXXXXX X&xxxx;XXXXXXXXX XXXXXXXXX (XX) 2021/849

xx xxx 11. března 2021,

xxxxxx xx xxx xxxxx xxxxxxxxxxxx xxxxxxxxxxx a vědeckému xxxxxxx mění xxxx 3 přílohy VI xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) č. 1272/2008 x&xxxx;xxxxxxxxxxx, označování x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx

(Xxxx x&xxxx;xxxxxxxx xxx XXX)

XXXXXXXX XXXXXX,

x&xxxx;xxxxxxx xx Smlouvu o fungování Xxxxxxxx xxxx,

x&xxxx;xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) x.&xxxx;1272/2008 xx xxx 16.&xxxx;xxxxxxxx&xxxx;2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx a balení xxxxx x&xxxx;xxxxx, x&xxxx;xxxxx x&xxxx;xxxxxxx směrnic 67/548/XXX x&xxxx;1999/45/XX x&xxxx;x&xxxx;xxxxx xxxxxxxx (XX) č. 1907/2006 (1), x&xxxx;xxxxxxx xx čl. 37 xxxx.&xxxx;5 xxxxxxxxx nařízení,

vzhledem k těmto xxxxxxx:

(1)

Xxxxxxx 3 v části 3 xxxxxxx XX xxxxxxxx (XX) č. 1272/2008 xxxxxxxx xxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxx xxxxxxxxxxxx xxxxx xx xxxxxxx xxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxx 2 xx 5 xxxxxxx I uvedeného xxxxxxxx.

(2)

Xxxxxxxx xxxxxxxx xxx chemické xxxxx (dále xxx „xxxxxxxx“) byly x&xxxx;xxxxxxx x&xxxx;xxxxxxx&xxxx;37 xxxxxxxx (XX) x.&xxxx;1272/2008 xxxxxxxxxx návrhy xx xxxxxxxx xxxxxxxxxxxxx xxxxxxxxxxx a označení xxxxxxxxx xxxxx x&xxxx;xx xxxxxxxxxxx xxxx xxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxx xxxxxxxxx xxxxxx xxxxx. Xxxx, xx Xxxxx xxx xxxxxxxxxx xxxxx (RAC) xxxxxxxx zohlednil xxxxxxxxxx xxxxxxxxxxxx stran, přijal x&xxxx;xxxxx xxxxxxx xxxxxxxxxx&xxxx;(2). Xxxxxxx xxxxxxxxxx xxxxxx XXX xxxx:

—

xxxxxxxxxx ze xxx 15.&xxxx;xxxxxx&xxxx;2019 xxx 1,2,4-xxxxxxx,

—

xxxxxxxxxx xx dne 15.&xxxx;xxxxxx&xxxx;2019 xxx 1,4-xxxxxx,

—

xxxxxxxxxx xx xxx 15. března 2019 xxx xxxxxx-xxxxxxxxx,

—

xxxxxxxxxx xx xxx 15. března 2019 xxx xxxxxxxxxxx (XXX),

—

xxxxxxxxxx xx xxx 15.&xxxx;xxxxxx&xxxx;2019 xxx xxxxxxxx (XXX),

—

xxxxxxxxxx ze xxx 15. března 2019 xxx xxxxxxxxxxxxx faktory xxx xxxxxxxxxxx xxxxxxxxxxxx xxx xxxxx xxxxxxxxx u látek xxxxxxxxxxxx xxx xxxxxxxxx x&xxxx;xxxxxxxx Xxxxxx (XX) 2016/1179,

—

xxxxxxxxxx xx xxx 15.&xxxx;xxxxxx&xxxx;2019 xxx N-{2-[[1,1’-bi(cyklopropyl)]-2-yl]fenyl}-3-(difluormethyl)-1-methyl-1H-pyrazol-4-karboxamid; xxxxxxx,

—

xxxxxxxxxx xx xxx 15.&xxxx;xxxxxx&xxxx;2019 xxx X-xxxxxxx-X-[1-xxxxxx-2-(2,4,6-xxxxxxxxxxxxx)xxxxx]-3-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxxx-4-xxxxxxxxxx; xxxxxxxxxxxxxx,

—

xxxxxxxxxx xx dne 15.&xxxx;xxxxxx&xxxx;2019 pro p-cymen; 1-xxxxxxxxx-4-xxxxxxxxxxxx,

—

xxxxxxxxxx xx dne 15.&xxxx;xxxxxx&xxxx;2019 pro x-xxxxxx-1,3-xxxx; α-xxxxxxxx; 1-isopropyl-4-methylcyklohexa-1,3-dien,

—

stanovisko xx xxx 15.&xxxx;xxxxxx&xxxx;2019 pro xxxxxxxxxxxxxx,

—

xxxxxxxxxx xx dne 15.&xxxx;xxxxxx&xxxx;2019 xxx (X)-x-xxxxxx-1,8-xxxx, x-xxxxxxx,

—

xxxxxxxxxx xx xxx 15.&xxxx;xxxxxx&xxxx;2019 xxx xxxxxxxxx-xxxxxx,

—

xxxxxxxxxx xx xxx 15. března 2019 xxx tolklofos-methyl (ISO), X-(2,6-xxxxxxx-x-xxxxx) X,X-xxxxxxxxxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 15.&xxxx;xxxxxx&xxxx;2019 xxx xxxxxxxxxx,

—

xxxxxxxxxx ze dne 15.&xxxx;xxxxxx&xxxx;2019 pro xxxxxxxx xxxxxxxx,

—

xxxxxxxxxx xx xxx 13.&xxxx;xxxxxx&xxxx;2019 xxx xxxxxxxxxxx,

—

xxxxxxxxxx xx dne 13.&xxxx;xxxxxx&xxxx;2019 xxx 2-xxxxxxxxxxx-1-xx,

—

xxxxxxxxxx ze xxx 13.&xxxx;xxxxxx&xxxx;2019 xxx 2,2-xxxxxx-2-xxxxxxxxxxxxx,

—

xxxxxxxxxx ze xxx 13.&xxxx;xxxxxx&xxxx;2019 pro 3-xxxxxxxxxxx-3,5,5-xxxxxxxxxxxxxxxxxxx-1-xxxx,

—

xxxxxxxxxx xx xxx 13. června 2019 xxx 6,6’-xx-xxxx-xxxxx-2,2’-xxxxxxxxxx-x-xxxxxx;

—

xxxxxxxxxx ze xxx 13.&xxxx;xxxxxx&xxxx;2019 xxx xxxxxxxxxxxx (ISO), N-(2,4-difluorfenyl)-2-[3-(trifluormethyl)fenoxy]pyridin-3-karboxamid;

—

stanovisko xx xxx 13. června 2019 xxx imidakloprid (ISO), 1-[(6-xxxxxxxxxxxx-3-xx)xxxxxx]-X-xxxxxxxxxxxxxxxxx-2-xxxxxxxxxx,

—

xxxxxxxxxx xx xxx 13.&xxxx;xxxxxx&xxxx;2019 pro xxxxxxxxxx,

—

xxxxxxxxxx xx xxx 13.&xxxx;xxxxxx&xxxx;2019 xxx X-xxxxxxxxxx xxxxxxxx,

—

xxxxxxxxxx xx dne 13.&xxxx;xxxxxx&xxxx;2019 xxx xxxxxxxx(2,6-xxxxxxxxxxxxx)-x-xxxxxxxxxxxxxxx,

—

xxxxxxxxxx ze xxx 20.&xxxx;xxxx&xxxx;2019 xxx 1,2-xxxxx-4-xxxxxxxxxxxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 20.&xxxx;xxxx&xxxx;2019 xxx 4-xxxxxxxxxxxx-2-xx,

—

xxxxxxxxxx xx xxx 20.&xxxx;xxxx&xxxx;2019 xxx xxxxxxxx xxxxxxx; xxxx xxxxxx; xxxxxxxxxxxx xxxxxxx, xxxxxxxxxx; xxxxxxxxxxxx xxxxxxx, bezvodý; sodnou xxx xxxxxxxx orthoborité; xxxxxxxxxxxx xxxxxxx, xxxxxxxxxx; xxxxxxxxxxxx disodný, xxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 20.&xxxx;xxxx&xxxx;2019 xxx xxxxxxxx xxxxxxxxxx,

—

xxxxxxxxxx xx dne 20.&xxxx;xxxx&xxxx;2019 xxx xxxxxxxx,

—

xxxxxxxxxx xx xxx 20.&xxxx;xxxx&xxxx;2019 xxx xxxxxxxxxx,

—

xxxxxxxxxx xx dne 20.&xxxx;xxxx&xxxx;2019 xxx xxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 20.&xxxx;xxxx&xxxx;2019 xxx xxxxxxxxx xxxxxxx,

—

xxxxxxxxxx xx xxx 20.&xxxx;xxxx&xxxx;2019 xxx xxxxxxxxxxxx (ISO); [(X)-(3-xxxxxxxxxxx)xxxxxxxxxx]-(X)-2-(4-xxxxxxxxxx)-3-xxxxxxxxxxxxxx,

—

xxxxxxxxxx ze dne 20.&xxxx;xxxx&xxxx;2019 xxx ethametsulfuron-methyl (XXX),

—

xxxxxxxxxx ze dne 20.&xxxx;xxxx&xxxx;2019 pro xxxxxxxx-X (XXX); (R)-2-(4-chlor-2-methylfenoxy)propanová xxxxxxxx x&xxxx;xxxx soli,

—

stanovisko xx xxx 20. září 2019 pro xxxxxx-xxxxxxxxx,

—

xxxxxxxxxx xx xxx 20.&xxxx;xxxx&xxxx;2019 xxx xxxxxxxxxx (XXX),

—

xxxxxxxxxx ze xxx 20.&xxxx;xxxx&xxxx;2019 xxx trifloxystrobin (XXX),

—

xxxxxxxxxx xx xxx 20.&xxxx;xxxx&xxxx;2019 xxx xxxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 5. prosince 2019 xxx 1,4-xxxxxxxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 5.&xxxx;xxxxxxxx&xxxx;2019 xxx 3xX,5X,6X,7xX,7xX,9xX,10X,12xX,12xX)-10-[(2X,3X,4X,5X)-3,4-xxxxxxxxx-5,6-xxxxxxxxxxxxxx-2-xx]-5,6-xxxxxxxxx-7x,9x-xxxxxxxxxxxxxxxxxxxxx-3X-xxxxx[x]xxxxxx[5,4-x]xxxxxx-3-xx; 24-xxxxxxxxxxxxxx,

—

xxxxxxxxxx xx xxx 5.&xxxx;xxxxxxxx&xxxx;2019 xxx 3-xxxxxxxxxxxxx,

—

xxxxxxxxxx ze dne 5.&xxxx;xxxxxxxx&xxxx;2019 pro karbendazim (XXX); methyl-N- (benzimidazol-2-yl)karbamát,

—

stanovisko xx xxx 5. prosince 2019 xxx xxxxxxxxxxxx xxx/xxxxx +/- 40/60; (XX)-α-xxxx-3-xxxxxxxxxxxx (1XX,3XX;1XX,3XX)-3-(2,2-xxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxxxxxxxxxxxx,

—

xxxxxxxxxx ze dne 5.&xxxx;xxxxxxxx&xxxx;2019 pro xxxxxxxx (XXX); (RS)-2-(4-isopropyl-4-methyl-5-oxo-4,5-dihydroimidazol-2-yl)-5-(methoxymethyl)nikotinovou kyselinu,

—

stanovisko xx dne 5. prosince 2019 xxx tetrafluorethylen,

—

stanovisko ze xxx 5. prosince 2019 xxx xxxxxxxxxxxx (XXX); X-xxxxx-{3-[(2-xxxxxxxxxxxx-5-xx)xxxxxx]-5-xxxxxx-1,3,5-xxxxxxxxxxx-4-xxxxxx}xxxx,

—

xxxxxxxxxx xx xxx 5.&xxxx;xxxxxxxx&xxxx;2019 xxx xxxxxxxxxx-xxxxx (XXX); xxxxx-4-[xxxxxxxxxxx(xxxxxxx)xxxxxxxx]-3,5-xxxxxxxxxxxxxxxxxxxxxxxxx.

(3)

Xxxxxx akutní xxxxxxxx (XXX) xx používají xxxxxxx ke xxxxxxxxx xxxxxxxxxxx akutní xxxxxxxx x&xxxx;xxxxxxxx xxxxxxxx xxxxxx x&xxxx;xxxxx xxxxxxxxxxxx xxxxx xxxxxxxxxxxxx xxxx látky xxxxxxxxxx xxxxxx xxxxxxxx. Xxxxxxxxx harmonizovaných hodnot XXX xx položek xxxxxxxxx x&xxxx;xxxxxxx XX xxxxxxxx (XX) x.&xxxx;1272/2008 xxxxxxxxx xxxxxxxxxxx xxxxxxxxxxx xxxxx x&xxxx;xxxxxxxxx podporu xxxxxxx xxxxxxxxx prosazováním. Xx základě xxxxxxx xxxxxxxxx xxxxxxxxx xxxxxxxxx xxxxx xxxxxxxx xxxxxxxxx xxxxxxx ATE xxx xxxx xxxxx, xxxxxxx-xxxxxxxxxxx xxxxxxxxx, xxxxxxxxxxxx-xxxxx tetraměďnatý x&xxxx;xxxxxxxxxxxx-xxxxx xxxxxxxxxxxx hydrát, xxxxxx xxxxxx (xxxxxxxx xxxxxxxxxxx kyselinou), uhličitan xxxxxxx – xxxxxxxx xxxxxxx (1:1) x&xxxx;xxxxxxxx xxxxxxx; hydroxid měďnatý, xxxxxxxxxxxx xxxxx; reakční xxxxxxxx xxxxxx měďnatého x&xxxx;xxxxxxxxx xxxxxxxxxx x&xxxx;xxxxx xxxxxxx, xxxxxxxxxxx, xxxxx xxxxxxxx xxxxxxxxxxxx ve xxxxxxxxxxxx výboru RAC xxx xxxx xxxxx. Xxxxxxx xxxxxxx XXX xx xxxx xxx xxxxxxxx do xxxxxxxxxxxxxx xxxxxxx xxxxxxx 3 x&xxxx;xxxxx 3 xxxxxxx XX nařízení (ES) x.&xxxx;1272/2008.

(4)

Xxxxxx obdržela dodatečné xxxxxxxxx, xxxxx xxxxxxxxxxx xxxxxxx xxxxxxxxx xxxxxxx xx xxxxxxxxxxxx XXX xx xxx 15. března 2019 xxxxxxxxxx xx xxxxxxxxx, xx xxx 20.&xxxx;xxxx&xxxx;2019 xxxxxxxx xx 4-methyl-2-pentanonu x&xxxx;xx xxx 20. září 2019 xxxxxxxx se dimethomorfu. Xxxxxx xxxx xxxxxxxxx xxxxxxxxx a neshledala xx xx xxxxxxxxxx x&xxxx;xxxx, xxx zpochybnily vědeckou xxxxxxx obsaženou xx xxxxxxxxxxxx XXX.

(5)

Xxxxxx proto xxxxxxxx xx vhodné xxxxxx, xxxxxxxxxxxx xx xxxxxx xxxxxxxxxxxxxx klasifikaci x&xxxx;xxxxxxxxxx určitých xxxxx.

(6)

Xxxxxxxx (XX) č. 1272/2008 by xxxxx xxxx být xxxxxxxxxxxxx xxxxxxxx xxxxxxx.

(7)

Xxxxxxxxxx xxxxxx nebo xxxxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx xx xxxxxx xxx, x&xxxx;xxxxxxxx xxxxxxxxxxx regulatorních xxxxxxxxx, xxxxxxxxxx ihned, xxxxxxx xxxxxxxxxx potřebují určitou xxxx xx xx, xxx přizpůsobili xxxxxxxxxx x&xxxx;xxxxxx látek x&xxxx;xxxxx xxxxx xxxx revidovaným xxxxxxxxxxxx x&xxxx;xxxxxxx stávající xxxxxx. Xxxx xxxx xx xxxxxx xxxxxxxx x&xxxx;xxxx, aby xxxxxxxxxx xxxx dostatek času xxxxxxxx xxxxxxxx xxxxx x&xxxx;xxxxxxxxx xxxxxxxx dodržování xxxxxxx xxxxxxxx požadavků, xxxxx vznikají v důsledku xxxx xxxxxxxxxxx podle xxxxxx nařízení. Xxxx xxxxxxxxx xxxxx zahrnovat xxxxxxxxx xxxxxxxxx x&xxxx;xx.&xxxx;22 xxxx.&xxxx;1 xxxx. f) xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) č. 1907/2006 (3) xxxx xxxxxxxxx xxxxxxxxx x&xxxx;xxxxxx&xxxx;50 xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) x.&xxxx;528/2012&xxxx;(4). Dodavatelům xx xxxx xxxx xxx xxxxxxxx používat nové xxxx xxxxxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxxxxxxx způsobem xxxxxxxxxxx označování x&xxxx;xxxxxx xx xxxxxxxxxxx xxxxxxx xxxx datem použitelnosti xxxxxx xxxxxxxx x&xxxx;xxx xxx xxxx xxxxxx x&xxxx;xxxxxxxx, aby byla xxxxxxxxx xxxxxx xxxxxx xxxxxxx xxxxxxxx xxxxxx x&xxxx;xxxxxxxxx prostředí x&xxxx;xxx xx xxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx,

XXXXXXX XXXX XXXXXXXX:

Xxxxxx&xxxx;1

Xxxxx xxxxxxxx (XX) x.&xxxx;1272/2008

Xxxxxxx 3 x&xxxx;xxxxx 3 xxxxxxx XX xxxxxxxx (XX) x.&xxxx;1272/2008 xx xxxx x&xxxx;xxxxxxx x&xxxx;xxxxxxxx xxxxxx nařízení.

Xxxxxx&xxxx;2

Xxxxx x&xxxx;xxxxxxxx a použitelnost

Toto xxxxxxxx xxxxxxxx x&xxxx;xxxxxxxx xxxxxxxx xxxx xx xxxxxxxxx v Úředním xxxxxxxx Xxxxxxxx xxxx.

Xxxxxxx xx xxx xxx 17.&xxxx;xxxxxxxx 2022.

Xxxxxxxx od druhého xxxxxxxxxxx tohoto xxxxxx xxxxx xxx látky x&xxxx;xxxxx xxxxxxxxxxxxx, označovány x&xxxx;xxxxxx x&xxxx;xxxxxxx x&xxxx;xxxxx xxxxxxxxx xxx xxx xxxx xxxxxx x&xxxx;xxxxxxxx.

Xxxx xxxxxxxx je xxxxxxx x&xxxx;xxxxx xxxxxxx x&xxxx;xxxxx použitelné xx xxxxx členských xxxxxxx.

X&xxxx;Xxxxxxx xxx 11.&xxxx;xxxxxx 2021.

Xx Xxxxxx

xxxxxxxxxxx

Xxxxxx XXX DER XXXXX

(1)&xxxx;&xxxx;Xx. věst. L 353, 31.12.2008, x.&xxxx;1.

(2)&xxxx;&xxxx;Xxxxxxxxxx xxxx xxxxxxxx xx xxxx xxxxxxxxxxx xxxxxxx: xxxxx://xxxx.xxxxxx.xx/xxxxxxxx-xx-xxx-xxxxxxxxxx-xxxxx-xxxxxxx/-/xxxxxxx/xxxx/-/xxXxxxxx/-/xxxXxxxxx/-/xxx_xxxxxxxXxxx/-/xxx_xxxxxxxXx/-/xxx_xxxxxx_xxxxxx/Xxxxxxx+Xxxxxxx/xxx_xxxxxxxxxXxxx/-/xxx_xxxxxxxxxXx/-/xxx_xxxxxxxx_xxxxxxxxxxXxxx/-/xxx_xxxxxxxx_xxxxxxxxxxXx/-/xxx_xxxxxxxx_xxxxxxxxXxxx/-/xxx_xxxxxxxx_xxxxxxxxXx/-/xxx_xxxxxxxx_xxxxxx/-/xxx_xxxxxxxxx/-/xxx_xxxxxxxxxxXxxx/-/xxx_xxxxxxxxxxXx/-/xxx_xxxxxxxxxx_xxxxxxxxx/-/

(3)&xxxx;&xxxx;Xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) x.&xxxx;1907/2006 xx xxx 18.&xxxx;xxxxxxxx&xxxx;2006x&xxxx;xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx a omezování chemických xxxxx, o zřízení Xxxxxxxx xxxxxxxx xxx xxxxxxxx xxxxx, x&xxxx;xxxxx xxxxxxxx 1999/45/XX x&xxxx;x&xxxx;xxxxxxx xxxxxxxx Xxxx (EHS) x.&xxxx;793/93, xxxxxxxx Komise (XX) x.&xxxx;1488/94, směrnice Rady 76/769/XXX a směrnic Xxxxxx 91/155/XXX, 93/67/EHS, 93/105/XX x&xxxx;2000/21/XX (Xx. věst. X&xxxx;396, 30.12.2006, s. 1).

(4)  Nařízení Xxxxxxxxxx parlamentu x&xxxx;Xxxx (XX) x.&xxxx;528/2012 ze xxx 22.&xxxx;xxxxxx&xxxx;2012x&xxxx;xxxxxxxx xxxxxxxxxx xxxxxxxxx xx xxx x&xxxx;xxxxxx používání(Úř. xxxx. X&xxxx;167, 27.6.2012, s. 1).

XXXXXXX

X&xxxx;xxxxxxx XX xxxxxxxx (XX) č. 1272/2008 xx xxxxxxx 3 x&xxxx;xxxxx 3 mění xxxxx:

1)

Xxxxxxxx xx xxxx xxxxxxx:

Xxxxxxxx xxxxx

Xxxxxxxx xxxxx

Xxxxx ES

Číslo XXX

Xxxxxxxxxxx

Xxxxxxxx

Xxxxxxxxxx xxxxxxx. limity, xxxxxxxxxxxxx xxxxxxx a ATE

Poznámky

Kódy xxxx a kategorií xxxxxxxxxxxxx

Xxxx xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx

Xxxx xxxxxxxxxxx symbolů a signálních xxxx

Xxxx standardních xxx x&xxxx;xxxxxxxxxxxxx

Xxxx doplň. xxxxxxxxxxxx xxx o nebezpečnosti

„601-093-00-6

1,4-dimethylnaftalen

209-335-9

571-58-4

Acute Xxx. 4

Xxx. Tox. 1

Xxx Xxxxx. 2

Aquatic Acute 1

Xxxxxxx Xxxxxxx 3

X302

X304

X319

X400

X412

XXX07

XXX08

XXX09

Xxx

X302

X304

X319

X410

xxxxxx: XXX&xxxx;= 1&xxxx;300  mg/kg XX

X&xxxx;= 1“

„601-094-00-1

1-isopropyl-4-methylbenzen;

p-cymen

202-796-7

99-87-6

Flam. Xxx. 3

Xxxxx Xxx. 3

Xxx. Xxx. 1

Xxxxxxx Xxxxxxx 2

X226

X331

X304

X411

XXX02

XXX06

XXX08

XXX09

Xxx

X226

X331

X304

X411

xxxxxxxxx: XXX&xxxx;= 3&xxxx;xx/x (xxxx)“

„601-095-00-7

x-xxxxxx-1,3-xxxx; 1-xxxxxxxxx-4-xxxxxxxxxxxxxxx-1,3-xxxx

α-xxxxxxxx

202-795-1

99-86-5

Xxxx. Xxx. 3

Xxxxx Xxx. 4

Xxxx Xxxx. 1

Xxx. Tox. 1

Xxxxxxx Chronic 2

H226

H302

H317

H304

H411

GHS02

GHS07

GHS08

GHS09

Dgr

H226

H302

H317

H304

H411

orální: XXX&xxxx;= 1&xxxx;680 &xxxx;xx/xx XX“

„602-110-00-X

xxxxxxxxxxxxxxxxx

204-126-9

116-14-3

Xxxx. 1X

X350

XXX08

Xxx

X350“

„604-095-00-5

6,6’-xx-xxxx-xxxxx-2,2’-xxxxxxxxxx-x-xxxxxx;

[XXXX]

204-327-1

119-47-1

Xxxx. 1X

X360X

XXX08

Xxx

X360X“

„606-152-00-X

(5-xxxxx-2-xxxxxxx-4-xxxxxx-3-xxxxxxx)(4,5,6-xxxxxxxxxx-x-xxxxx)xxxxxxxx; xxxxxxxxxx

-

688046-61-9

Xxxx. 2

Xxxxxxx Chronic 1

X351

X410

XXX08

XXX09

Xxx

X351

X410

X&xxxx;= 1“

„607-747-00-7

2,2-xxxxxx-2-xxxxxxxxxxxxx; [DBNPA]

233-539-7

10222-01-2

Acute Xxx. 2

Xxxxx Tox. 3

XXXX RE 1

Xxxx Xxxxx. 2

Eye Dam. 1

Xxxx Xxxx. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X330

X301

X372 (xxxxxxx xxxxx) (xxxxxxxxx)

X315

X318

X317

X400

X410

XXX06

XXX08

XXX05

XXX09

Xxx

X330

X301

X372 (xxxxxxx cesty) (xxxxxxxxx)

X315

X318

X317

X410

xxxxxxxxx: XXX&xxxx;= 0,24&xxxx;xx/x (xxxxx nebo xxxx)

xxxxxx: XXX&xxxx;= 118 mg/kg TH

M = 1

X&xxxx;= 1“

„607-748-00-2

[X-(X,X)]-5-(-1-xxxxxxx-2,6,6-xxxxxxxxx-4-xxxxxxxxxxx-2-xx-1-xx)-3-xxxxxxxxxxx-2,4-xxxxxxx kyselina;

S-abscisová xxxxxxxx

244-319-5

21293-29-8

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

H400

H410

GHS09

Wng

H410

M = 1

X&xxxx;= 1“

„607-749-00-8

xxxxxx-xxxxxxxxx

204-317-7

119-36-8

Xxxx. 2

Xxxxx Tox. 4

Xxxx Xxxx. 1X

Xxxxxxx Xxxxxxx 3

H361d

H302

H317

H412

GHS07

GHS08

Wng

H361d

H302

H317

H412

orální: ATE = 890&xxxx;xx/xx TH“

„607-750-00-3

citronová kyselina

201-069-1

77-92-9

Eye Xxxxx. 2

XXXX SE 3

X319

X335

XXX07

Xxx

X319

X335“

„607-751-00-9

xxxxxxxxxxxxxxx-xxxxxx (XXX);

xxxxxx-2-({[4-xxxxxx-6-(xxxxxxxxxxx)-1,3,5-xxxxxxx-2-xx]xxxxxxxxx}xxxxxxxxx)xxxxxxx

-

97780-06-8

Xxx Xxxxx. 2

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X319

X400

X410

XXX07

XXX09

Xxx

X319

X410

X&xxxx;= 1 000

M = 100“

„607-752-00-4

xxxxxxxxxx-xxxxx (ISO);

ethyl-4-[cyklopropyl(hydroxy)methylen]-3,5-dioxocyklohexankarboxylát

-

95266-40-3

STOT XX 2

Xxxx Sens. 1X

Xxxxxxx Xxxxxxx 1

X373 (xxxxxxxxxxxxxxxxxx xxxxx)

X317

X410

XXX08

XXX07

XXX09

Xxx

X373 (gastrointestinální xxxxx)

X317

X410

X&xxxx;= 1“

„607-753-00-X

(3xX,5X,6X,7xX,7xX,9xX,10X,12xX,12xX)-10-[(2X,3X,4X,5X)-3,4-xxxxxxxxx-5,6-xxxxxxxxxxxxxx-2-xx]-5,6-xxxxxxxxx-7x,9x-xxxxxxxxxxxxxxxxxxxxx-3X-xxxxx[x]xxxxxx[5,4-x]xxxxxx-3-xx; 24-xxxxxxxxxxxxxx

-

78821-43-9

Xxxxxxx Chronic 4

X413

X413“

„607-754-00-5

xxxxxx-xxxxxxxxx

204-262-9

118-58-1

Xxxx Xxxx. 1B

H317

GHS07

Wng

H317“

„607-755-00-0

(RS)-1-{1-ethyl-4-[4-mesyl-3-(2-methoxyethoxy)-o-toluoyl]pyrazol-5-yloxy}ethyl-methyl-karbonát;

tolpyralát

-

1101132-67-5

Carc. 2

Xxxx. 2

STOT XX 2

Xxxxxxx Acute 1

Xxxxxxx Xxxxxxx 1

X351

X361xx

X373 (oči)

H400

H410

GHS08

GHS09

Wng

H351

H361fd

H373 (xxx)

X410

X&xxxx;= 10

X&xxxx;= 100“

„613-337-00-9

prothiokonazol (XXX);

2-[2-(1-xxxxxxxxxxxxxxxx)-3-(2-xxxxxxxxxx)-2-xxxxxxxxxxxxx]-2,4-xxxxxxx-3X-1,2,4-xxxxxxx-3-xxxxx

-

178928-70-6

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

H400

H410

GHS09

Wng

H410

M = 10

X&xxxx;= 1“

„613-338-00-4

xxxxxxxxxxx (ISO); S-[(6-chlor-2-oxooxazolo[4,5-b]pyridin-3(2H)-yl)methyl]-(O,O-dimethyl)thiofosfát

252-626-0

35575-96-3

Carc. 2

Xxxxx Xxx. 3

Xxxxx Xxx. 4

XXXX XX 1

Xxxx Xxxx. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X351

X331

X302

X370 (nervový xxxxxx)

X317

X400

X410

XXX06

XXX08

XXX09

Xxx

X351

X331

X302

X370 (xxxxxxx systém)

H317

H410

inhalační: XXX&xxxx;= 0,5&xxxx;xx/x (xxxxx nebo xxxx)

xxxxxx: ATE = 500&xxxx;xx/xx XX

X&xxxx;= 1 000

M = 1 000 “

„613-339-00-X

3-xxxxxxxxxxxxx

215-925-7

1453-58-3

Xxxx. 1X

Xxxxx Xxx. 4

XXXX XX 2

Xxxx Xxxx. 1

Xxx Dam. 1

X360X

X302

X373 (xxxxx)

X314

X318

XXX08

XXX07

XXX05

Xxx

X360X

X302

X373 (xxxxx)

X314

xxxxxx: XXX&xxxx;= 500&xxxx;xx/xx XX“

„613-340-00-5

xxxxxxxx (XXX); 2-(2-xxxxxxxxxxx)-4,4-xxxxxxxx-1,2-xxxxxxxxxx-3-xx

-

81777-89-1

Xxxxx Xxx. 4

Xxxxx Tox. 4

Aquatic Xxxxx 1

Xxxxxxx Xxxxxxx 1

X332

X302

X400

X410

XXX07

XXX09

Xxx

X332

X302

X410

xxxxxxxxx: ATE = 4,85 mg/l (xxxxx nebo mlha)

orální: XXX&xxxx;= 768 mg/kg XX

X&xxxx;= 1

X&xxxx;= 1“

„614-030-00-2

emamektin-benzoát (XXX); (4“X)-4“-xxxxx-4“-(xxxxxxxxxxx)xxxxxxxxxx X1-xxxxxxx

-

155569-91-8

Xxxxx Xxx. 3

Xxxxx Xxx. 3

Acute Xxx. 3

XXXX XX 1

XXXX XX 1

Xxx Xxx. 1

Aquatic Xxxxx 1

Xxxxxxx Xxxxxxx 1

H331

H311

H301

H370 (xxxxxxx xxxxxx)

X372 (xxxxxxx xxxxxx)

X318

X400

X410

XXX06

XXX05

XXX08

XXX09

Xxx

X331

X311

X301

X370 (xxxxxxx xxxxxx)

X372 (xxxxxxx xxxxxx)

X318

X410

xxxxxxxxx:

XXX&xxxx;= 0,663

xx/x (xxxxx nebo xxxx)

xxxxxxxx:

XXX&xxxx;= 300

xx/xx TH

orální: ATE =

60&xxxx;xx/xx XX

XXXX RE 1; X372: C ≥ 5 %; XXXX RE 2; X373: 0,5&xxxx;% ≤ X&xxxx;&xx;&xxxx;5&xxxx;%

X&xxxx;= 10&xxxx;000

X&xxxx;= 10&xxxx;000 “

„616-234-00-7

X-xxxxxxx-X-[1-xxxxxx-2-(2,4,6-xxxxxxxxxxxxx)-xxxxx]-3-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxxx-4-xxxxxxxxxx; pydiflumetofen

-

1228284-64-7

Carc. 2

Xxxx. 2

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X351

X361x

X400

X410

XXX08

XXX09

Xxx

X351

X361x

X410

X&xxxx;= 1

X&xxxx;= 1“

„616-235-00-2

X-{2-[[1,1’-xx(xxxxxxxxxxx)]-2-xx]xxxxx}-3-(xxxxxxxxxxxxx)-1-xxxxxx-1X-xxxxxxx-4-xxxxxxxxxx; xxxxxxx

-

874967-67-6

Xxxx. 2

Xxxxxxx Xxxxx 1

Xxxxxxx Chronic 2

X351

X400

X411

XXX08

XXX09

Xxx

X351

X410

X&xxxx;= 1“

2)

xxxxxxx xxxxxxxxxxxx xxxxxxxxx číslům 005-007-00-2; 005-008-00-8; 005-011-00-4; 005-011-01-1; 005-011-02-9; 006-069-00-3; 006-076-00-1; 015-113-00-0; 028-007-00-4; 029-002-00-X; 029-015-00-0; 029-016-00-6; 029-017-00-1; 029-018-00-7; 029-019-01-X; 029-020-00-8; 029-021-00-3; 029-022-00-9; 029-023-00-4; 601-029-00-7; 601-096-00-2; 603-024-00-5; 603-066-00-4; 603-098-00-9; 606-004-00-4; 607-421-00-4; 607-424-00-0; 607-434-00-5; 608-058-00-4; 612-067-00-9; 612-252-00-4; 613-048-00-8; 613-102-00-0; 613-111-00-X; 613-166-00-X; 613-208-00-7; 613-267-00-9; 613-282-00-0; 616-032-00-9; 616-106-00-0 x&xxxx;616-113-00-9 xx xxxxxxxxx xxxxxx xxxxxxxxx:

Xxxxxxxx xxxxx

Xxxxxxxx xxxxx

Xxxxx ES

Číslo XXX

Xxxxxxxxxxx

Xxxxxxxx

Xxxxxxxxxx xxxxxxx. limity, xxxxxxxxxxxxx xxxxxxx x&xxxx;XXX

Xxxxxxxx

Xxxx xxxx x&xxxx;xxxxxxxxx xxxxxxxxxxxxx

Xxxx xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx

Xxxx výstražných xxxxxxx x&xxxx;xxxxxxxxxx xxxx

Xxxx xxxxxxxxxxxx xxx o nebezpečnosti

Kódy xxxxx. xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx

„005-007-00-2

xxxxxxxx xxxxxx [1]

kyselina xxxxxx [2]

233-139-2 [1]

234-343-4 [2]

10043-35-3 [1]

11113-50-1 [2]

Xxxx. 1X

X360XX

XXX08

Xxx

X360XX“

„005-008-00-8

xxxx xxxxxx

215-125-8

1303-86-2

Xxxx. 1B

H360FD

GHS08

Dgr

H360FD“

„005-011-00-4

tetraboritan xxxxxxx, xxxxxxxxxx; [1]

xxxxxxxxxxxx xxxxxxx, xxxxxxx; [2]

sodná xxx kyseliny xxxxxxxxxxx [3]

xxxxxxxxxxxx disodný, xxxxxxxxxx [4]

xxxxxxxxxxxx disodný xxxxxxxxxxx [5]

235-541-3 [1]

215-540-4 [2]

237-560-2 [3]

215-540-4 [4]

215-540-4 [5]

12267-73-1 [1]

1330-43-4 [2]

13840-56-7 [3]

1303-96-4 [4]

12179-04-3 [5]

Repr. 1B

H360FD

GHS08

Dgr

H360FD“

„006-069-00-3

thiofanát-methyl (XXX);

xxxxxxxx (1,2-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxxxx;

xxxxxxxx 4,4′-(o-fenylen)bis(3-thioallofanát)

245-740-7

23564-05-8

Carc. 2

Xxxx. 2

Xxxxx Xxx. 4

Xxxx Sens. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X351

X341

X332

X317

X400

X410

XXX08

XXX07

XXX09

Xxx

X351

X341

X332

X317

X410

xxxxxxxxx: ATE = 1,7 mg/l

(prach xxxx xxxx)

X&xxxx;= 10

M = 10“

„006-076-00-1

xxxxxxxx (XXX); X,X’-xxxxxxxxxx(xxxxxxxxxxxxxx) xxxxxxxxx, xxxxxxxxx xxxxxxx xx xxxxxxxxxx xxxx

-

8018-01-7

Xxxx. 2

Xxxx. 1X

XXXX RE 2

Xxxx Xxxx. 1

Aquatic Xxxxx 1

Xxxxxxx Xxxxxxx 1

X351

X360X

X373 (xxxxxx xxxxx, xxxxxxx systém)

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H351

H360D

H373 (štítná xxxxx, nervový xxxxxx)

X317

X410

X&xxxx;= 10

X&xxxx;= 10“

„015-113-00-0

xxxxxxxxx-xxxxxx (XXX);

X-(2,6-xxxxxxx-x-xxxxx) X,X-xxxxxxxxxxxxxxxxxx

260-515-3

57018-04-9

Xxxx Sens. 1X

Xxxxxxx Xxxxx 1

Aquatic Xxxxxxx 1

X317

X400

X410

XXX07

XXX09

Xxx

X317

X410

X&xxxx;= 1

X&xxxx;= 1“

„028-007-00-4

xxxxxxxx xxxxxxxx;

xxxxxxxxx xxxxxxxxx; [1]

xxxxxxxxxxxx [2]

234-829-6 [1]

- [2]

12035-72-2 [1]

12035-71-1 [2]

Xxxx. 1&xxxx;X

Xxxx. 2

Xxxxx Xxx. 3

STOT XX 1

Xxxx Xxxx. 1

Xxxxxxx Acute 1

Xxxxxxx Xxxxxxx 1

H350i

H341

H331

H372**

H317

H400

H410

GHS08

GHS06

GHS09

Dgr

H350i

H341

H331

H372**

H317

H410

inhalační:

ATE = 0,92&xxxx;xx/x

(xxxxx xxxx xxxx)“

„029-002-00-X

xxxx xxxxx

215-270-7

1317-39-1

Xxxxx Xxx. 4

Xxxxx Xxx. 4

Xxx Xxx. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Chronic 1

X332

X302

X318

X400

X410

XXX07

XXX05

XXX09

Xxx

X332

X302

X318

X410

xxxxxxxxx: XXX&xxxx;= 3,34&xxxx;xx/x (xxxxx xxxx mlha)

orální: XXX&xxxx;= 500 mg/kg XX

X&xxxx;= 100

X&xxxx;= 10“

„029-015-00-0

xxxxxxxxxxxx xxxxx

214-183-1

1111-67-7

Xxxxxxx Xxxxx 1

Aquatic Xxxxxxx 1

X400

X410

XXX09

Xxx

X410

XXX032

X&xxxx;= 10

M = 10“

„029-016-00-6

xxxx xxxxxxx

215-269-1

1317-38-0

Xxxxxxx Acute 1

Xxxxxxx Xxxxxxx 1

X400

X410

XXX09

Xxx

X410

X&xxxx;= 100

M = 10“

„029-017-00-1

xxxxxxx-xxxxxxxxxxx xxxxxxxxx

215-572-9

1332-65-6

Xxxxx Tox. 4

Xxxxx Xxx. 3

Xxxxxxx Xxxxx 1

Aquatic Chronic 1

X332

X301

X400

X410

XXX06

XXX09

Xxx

X332

X301

X410

xxxxxxxxx: XXX&xxxx;= 2,83&xxxx;xx/x (xxxxx nebo xxxx)

xxxxxx: XXX&xxxx;= 299&xxxx;xx/xx XX

X&xxxx;= 10

X&xxxx;= 10“

„029-018-00-7

xxxxxxxxxxxx-xxxxx xxxxxxxxxxxx; [1]

xxxxxxxxxxxx-xxxxx tetraměďnatý hydrát [2]

215-582-3 [1]

215-582-3 [2]

1333-22-8 [1]

12527-76-3 [2]

Xxxxx Xxx. 4

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

orální: ATE = 500&xxxx;xx/xx TH

M = 10

M = 10“

„029-019-01-X

xxxxxx xxxxxx (potažené xxxxxxxxxxx kyselinou)

-

-

Acute Tox. 3

Xxxxx Xxx. 4

Xxx Xxxxx. 2

Xxxxxxx Xxxxx 1

Xxxxxxx Chronic 1

X331

X302

X319

X400

X410

XXX06

XXX09

Xxx

X331

X302

X319

X410

xxxxxxxxx: XXX&xxxx;= 0,733&xxxx;xx/x (prach xxxx mlha)

orální: XXX&xxxx;= 500&xxxx;xx/xx XX

X&xxxx;= 10

X&xxxx;= 10“

„029-020-00-8

xxxxxxxxx xxxxxxx – xxxxxxxx měďnatý (1:1)

235-113-6

12069-69-1

Xxxxx Xxx. 4

Acute Xxx. 4

Xxx Xxxxx. 2

Xxxxxxx Xxxxx 1

Aquatic Chronic 1

X332

X302

X319

X400

X410

XXX07

XXX09

Xxx

X332

X302

X319

X410

xxxxxxxxx: ATE = 1,2&xxxx;xx/x (xxxxx nebo xxxx)

xxxxxx: XXX&xxxx;= 500&xxxx;xx/xx XX

X&xxxx;= 10

X&xxxx;= 10“

„029-021-00-3

hydroxid xxxxxxx

243-815-9

20427-59-2

Xxxxx Xxx. 2

Acute Tox. 4

Xxx Dam. 1

Xxxxxxx Xxxxx 1

Aquatic Chronic 1

X330

X302

X318

X400

X410

XXX06

XXX05

XXX09

Xxx

X330

X302

X318

X410

xxxxxxxxx: XXX&xxxx;= 0,47 mg/l (xxxxx xxxx xxxx)

xxxxxx: XXX&xxxx;= 500&xxxx;xx/xx XX

X&xxxx;= 10

X&xxxx;= 10“

„029-022-00-9

xxxxxxxxxxx jícha;

reakční xxxxxxxx xxxxxx měďnatého x&xxxx;xxxxxxxxx vápenatého

-

8011-63-0

Acute Xxx. 4

Xxx Xxx. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X332

X318

X400

X410

XXX07

XXX05

XXX09

Xxx

X332

X318

X410

xxxxxxxxx: XXX&xxxx;= 1,97&xxxx;xx/x (xxxxx xxxx xxxx)

X&xxxx;= 10

X&xxxx;= 1“

„029-023-00-4

xxxxx xxxxxxx, xxxxxxxxxxx

231-847-6

7758-99-8

Xxxxx Xxx. 4

Eye Xxx. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X302

X318

X400

X410

XXX07

XXX05

XXX09

Xxx

X302

X318

X410

xxxxxx: XXX&xxxx;= 481 mg/kg TH

M = 10

X&xxxx;= 1“

„601-029-00-7

dipenten;

limonen [1]

(S)-p-mentha-1,8-dien; x-xxxxxxx [2]

xxxxx-1-xxxxxx-4-(1-xxxxxxxxxxx)xxxxxxxxxx; [3]

(±)-1-methyl-4-(1-methylvinyl)cyklohexen [4]

205-341-0 [1]

227-815-6 [2]

229-977-3 [3]

231-732-0 [4]

138-86-3 [1]

5989-54-8 [2]

6876-12-6 [3]

7705-14-8 [4]

Xxxx. Xxx. 3

Skin Xxxxx. 2

Xxxx Xxxx. 1

Aquatic Xxxxx 1

Xxxxxxx Xxxxxxx 1

X226

X315

X317

X400

X410

XXX02

XXX07

XXX09

Xxx

X226

X315

X317

X410

X“

„601-096-00-2

(X)-x-xxxxxx-1,8-xxxx;

x-xxxxxxx

227-813-5

5989-27-5

Xxxx. Liq. 3

Xxxx Xxxxx. 2

Xxxx Xxxx. 1X

Xxx. Xxx. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 3

X226

X315

X317

X304

X400

X412

XXX02

XXX07

XXX08

XXX09

Xxx

X226

X315

X317

X304

X410

X&xxxx;= 1“

„603-024-00-5

1,4-xxxxxx

204-661-8

123-91-1

Xxxx. Xxx. 2

Xxxx. 1X

XXXX XX 3

Xxx Irrit. 2

X225

X350

X335

X319

XXX02

XXX08

XXX07

Xxx

X225

X350

X335

X319

XXX019

XXX066

X“

„603-066-00-4

7-xxx-3-xxxxxxxxxxxxxxx[4.1.0]xxxxxx; 1,2-xxxxx-4-(1,2-xxxxxxxxxx)xxxxxxxxxx 4-vinylcyklohexendiepoxid

203-437-7

106-87-6

Carc. 1X

Xxxx. 2

Xxxx. 1X

Xxxxx Xxx. 3

Xxxxx Xxx. 4

H350

H341

H360F

H331

H302

GHS08

GHS06

Dgr

H350

H341

H360F

H331

H302

inhalační: XXX&xxxx;= 0,5&xxxx;xx/x (xxxxx xxxx mlha)

oral: XXX&xxxx;= 1&xxxx;847 &xxxx;xx/xx TH“

„603-098-00-9

2-fenoxyethan-1-ol

204-589-7

122-99-6

Acute Xxx. 4

XXXX XX 3

Xxx Xxx. 1

X302

X335

X318

XXX05

XXX07

Xxx

X302

X335

X318

xxxxxx:

XXX&xxxx;= 1&xxxx;394 &xxxx;xx/xx TH“

„606-004-00-4

4-methylpentan-2-on; xxxxxxxx(xxxxxx)xxxxx

203-550-1

108-10-1

Xxxx. Liq. 2

Xxxx. 2

Xxxxx Xxx. 4

XXXX XX 3

Xxx Xxxxx. 2

X225

X351

X332

X336

X319

XXX02

XXX07

XXX08

Xxx

X225

X351

X332

X336

X319

XXX066

xxxxxxxxx: ATE = 11&xxxx;xx/x (xxxx)“

„607-421-00-4

xxxxxxxxxxxx (ISO);

α-kyan-3-fenoxybenzyl 3-(2,2-xxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxxxxxxxxxxxx; xxxxxxxxxxxx xxx/xxxxx +/- 40/60

257-842-9

52315-07-8

Xxxxx Tox. 4

Xxxxx Xxx. 4

STOT XX 3

XXXX XX 2

Aquatic Xxxxx 1

Aquatic Xxxxxxx 1

X332

X302

X335

X373 (xxxxxxx systém)

H400

H410

GHS07

GHS08

GHS09

Wng

H332

H302

H335

H373 (xxxxxxx systém)

H410

orální; XXX&xxxx;= 500&xxxx;xx/xx TH

inhalační; XXX&xxxx;= 3,3&xxxx;xx/x (xxxxx xxxx xxxx)

X&xxxx;= 100000

X&xxxx;= 100000“

„607-424-00-0

trifloxystrobin (XXX); xxxxxx-(X)-α-(xxxxxxxxxxxx)-2-{[(X)-({1-[3-(xxxxxxxxxxxxxx)xxxxx]xxxxxxxxx}xxxxx)xxx]xxxxxx}xxxxxx-1-xxxxxx

-

141517-21-7

Xxxx.

Xxxx Sens. 1

Xxxxxxx Xxxxx 1

Aquatic Xxxxxxx 1

X362

X317

X400

X410

XXX07

XXX09

Xxx

X362

X317

X410

X&xxxx;= 100

X&xxxx;= 10“

„607-434-00-5

xxxxxxxx-X (XXX) [1] x&xxxx;xxxx xxxx;

(X)-2-(4-xxxxx-2-xxxxxxxxxxxx)xxxxxxxxx kyselina [1] a její soli

240-539-0 [1]

16484-77-8 [1]

Xxxxx Tox. 4

Xxx Dam. 1

Aquatic Xxxxx 1

Xxxxxxx Chronic 1

X302

X318

X400

X410

XXX07

XXX05

XXX09

Xxx

X302

X318

X410

xxxxxx: XXX&xxxx;= 431&xxxx;xx/xx XX

X&xxxx;= 10

X&xxxx;= 10“

„608-058-00-4

xxxxxxxxxxxx (XXX);

[(X)-(3-xxxxxxxxxxx)xxxxxxxxxx]-(X)-2-(4-xxxxxxxxxx)-3-xxxxxxxxxxxxxx

-

66230-04-4

Xxxxx Xxx. 3

Acute Xxx. 3

XXXX SE 1

XXXX XX 2

Skin Xxxx. 1

Xxxxxxx Xxxxx 1

Xxxxxxx Chronic 1

X331

X301

X370 (xxxxxxx xxxxxx)

X373

X317

X400

X410

XXX06

XXX08

XXX09

Xxx

X331

X301

X370 (nervový xxxxxx)

X373

X317

X410

xxxxxx; XXX&xxxx;= 88,5 mg/kg XX

xxxxxxxxx; ATE = 0,53&xxxx;xx/x (xxxxx nebo xxxx)

X&xxxx;= 10&xxxx;000

X&xxxx;= 10&xxxx;000 “

„612-067-00-9

3-(xxxxxxxxxxx)-3,5,5-xxxxxxxxxxxxxxxxxxx-1-xxxx

220-666-8

2855-13-2

Xxxxx Xxx. 4

Xxxx Corr. 1X

Xxx Xxx. 1

Xxxx Xxxx. 1&xxxx;X

X302

X314

X318

X317

XXX05

XXX07

Xxx

X302

X314

X317

xxxxxx: XXX&xxxx;= 1&xxxx;030 &xxxx;xx/xx TH

Skin Xxxx. 1&xxxx;X; H317: X&xxxx;≥&xxxx;0,001&xxxx;%“

„612-252-00-4

xxxxxxxxxxxx (XXX);

(X)-1-(6-xxxxx-3-xxxxxxxxxxxxx)-X-xxxxxxxxxxxxxxxxx-2-xxxxxxxxxxx;

(2X)-1-[(6-xxxxxxxxxxxx-3-xx) xxxxxx]-X-xxxxxxxxxxxxxxxxx-2-xxxx

428-040-8

138261-41-3

Xxxxx Xxx. 3

Xxxxxxx Xxxxx 1

Xxxxxxx Chronic 1

X301

X400

X410

XXX06

XXX09

Xxx

X301

X410

xxxxxx: XXX&xxxx;= 131&xxxx;xx/xx XX

X&xxxx;= 100

X&xxxx;= 1&xxxx;000 “

„613-048-00-8

karbendazim (XXX); xxxxxx-X- (benzimidazol-2-yl)karbamát

234-232-0

10605-21-7

Muta. 1X

Xxxx. 1X

Xxxx Xxxx. 1

Xxxxxxx Acute 1

Aquatic Xxxxxxx 1

H340

H360FD

H317

H400

H410

GHS07

GHS08

GHS09

Dgr

H340

H360FD

H317

H410

M = 10

X&xxxx;= 10“

„613-102-00-0

xxxxxxxxxxx (XXX); (E,Z)-4-(3-(4-chlorfenyl)-3-(3,4-dimethoxyfenyl)acryloyl)morfolin

404-200-2

110488-70-5

Repr. 1X

Xxxxxxx Chronic 2

X360X

X411

XXX08

XXX09

Xxx

X360X

X411“

„613-111-00-X

1,2,4-xxxxxxx

206-022-9

288-88-0

Xxxx. 1X

Xxxxx Xxx. 4

Xxx Xxxxx. 2

X360XX

X302

X319

XXX08

XXX07

Xxx

X360XX

X302

X319

xxxxxx: XXX&xxxx;= 1&xxxx;320 &xxxx;xx/xx TH“

„613-166-00-X

flumioxazin (XXX);

7-xxxxx-4-(xxxx-2-xx-1-xx)-6-(3,4,5,6-xxxxxxxxxxxxxxxxxxx)-1,4-xxxxxxxxxx-3(2X)-xx

-

103361-09-7

Xxxx. 2

Xxxxxxx Xxxxx 1

Xxxxxxx Chronic 1

X361x

X400

X410

XXX08

XXX09

Xxx

X361x

X410

X&xxxx;= 1&xxxx;000

X&xxxx;= 1&xxxx;000 “

„613-208-00-7

xxxxxxxx (XXX);

(XX)-2-(4-xxxxxxxxx-4-xxxxxx-5-xxx-4,5-xxxxxxxxxxxxxxx-2-xx)-5-(xxxxxxxxxxxxx)xxxxxxxxxx xxxxxxxx

-

114311-32-9

Xxxx. 2

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X361x

X400

X410

XXX08

XXX09

Xxx

X361x

X410

X&xxxx;= 10

X&xxxx;= 10“

„613-267-00-9

xxxxxxxxxxxx (XXX);

X-xxxxx-{3-[(2-xxxxxxxxxxxx-5-xx)xxxxxx]-5-xxxxxx-1,3,5-xxxxxxxxxxx-4-xxxxxx}xxxx

428-650-4

153719-23-4

Xxxx. 2

Xxxxx Xxx. 4

Xxxxxxx Acute 1

Xxxxxxx Xxxxxxx 1

X361xx

X302

X400

X410

XXX07

XXX08

XXX09

Xxx

X361xx

X302

X410

xxxxxx: ATE = 780&xxxx;xx/xx TH

M = 10

X&xxxx;= 10“

„613-282-00-0

xxxxxxxxxxxx (XXX);

(1XX)-5-[(X)-4-xxxxxxxxxxxxxxx]-2,2-xxxxxxxx-1-(1X-1,2,4-xxxxxxx-1-xxxxxxxx)xxxxxxxxxxx-1-xx

-

138182-18-0

Xxxx. 2

XXXX XX 2

Aquatic Xxxxx 1

Xxxxxxx Chronic 1

H361f

H373

H400

H410

GHS08

GHS09

Wng

H361f

H373

H410

M = 1

X&xxxx;= 1“

„616-032-00-9

xxxxxxxxxxxx (XXX);

X-(2,4-xxxxxxxxxxxx)-2-[3-(xxxxxxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxxxx; 2′,4′-xxxxxxx-2-(α,α,α-xxxxxxxx-x-xxxxxxxx)xxxxxxxxxxxxx

-

83164-33-4

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X400

X410

XXX09

Xxx

X410

X&xxxx;= 10&xxxx;000

X&xxxx;= 1&xxxx;000 “

„616-106-00-0

fenmedifam (XXX); xxxxxx-X-(3-{[X-(3-(xxxxxxxxxxx)xxxxxxxxx]xxx}xxxxx)xxxxxxxx

237-199-0

13684-63-4

Xxxxxxx Acute 1

Xxxxxxx Xxxxxxx 1

X400

X410

XXX09

Xxx

X410

X&xxxx;= 10

X&xxxx;= 10“

„616-113-00-9

xxxxxxxxxxx (XXX);

xxxxx-X-{3-[(X-xxxxxxxxxxxxxx)xxx]xxxxx}xxxxxxxx

237-198-5

13684-56-5

Xxxx. 2

Xxxxxxx Xxxxx 1

Xxxxxxx Xxxxxxx 1

X361x

X400

X410

XXX08

XXX09

Xxx

X361x

X410

X&xxxx;= 10

X&xxxx;= 10“

3)

xxxxxxx xxxxxxxxxxxx xxxxxxxxxx xxxxx 015-192-00-1 xx xxxxxxx.